Sydney M. Finegold

Sydney M. Finegold's AcademicInfluence.com Rankings

Sydney M. Finegold

Philosophy

#2501

World Rank

#4255

Historical Rank

#884

USA Rank

Logic

#620

World Rank

#1100

Historical Rank

#235

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Sydney M. Finegold Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sydney "Sid" Martin Finegold was an American physician, medical school professor, and medical researcher, specializing in anaerobic bacteriology. Biography Born in New York City to Russian, Jewish immigrant parents who worked as pharmacists, Sydney Finegold had a sister and an older brother. The family moved to Los Angeles in the early 1930s. Sydney Finegold graduated in 1943 from the University of California, Los Angeles with a bacteriology major and served from 1943 to 1945 in the US Marine Corps. After WWII ended, he matriculated at the University of Texas Medical Branch in Galveston, where he graduated in 1949 with an M.D. In 1947 he married Mary Louise Saunders, a fellow medical student. From 1949 to 1950 he was a medical intern in internal medicine at the US Public Health Service in Galveston. From 1950 to 1952 he was a resident in internal medicine at the University of Minnesota Medical School, where he was mentored by Wesley W. Spink and Wendell H. Hall. From 1951 to 1952 Finegold held his first faculty appointment at the University of Minnesota Medical School. During the Korean War he was recalled to military service. From 1952 to 1953 he was a regimental surgeon in the US Army in Japan and Korea. From 1953 to 2000 he was a physician at the Wadsworth VA Hospital, Los Angeles. During the beginning of his career there he was mentored by William L. Hewitt. From 1968 to 2000 Finegold was Professor of Medicine, Microbiology, Immunology and Molecular Genetics at the UCLA School of Medicine. From 1990 to 2000 he was the editor-in-chief of the journal Clinical Infectious Diseases .

(See a Problem?)

Sydney M. Finegold's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Wadsworth Anaerobic Bacteriology Manual (1980) (1201)
Pyrosequencing study of fecal microflora of autistic and control children. (2010) (810)
Bailey and Scott's Diagnostic microbiology (1982) (796)
Anaerobic bacteria in human disease (1977) (745)
Gastrointestinal microflora studies in late-onset autism. (2002) (674)
A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis (1991) (656)
Selective and differential medium for isolation of Clostridium difficile (1979) (640)
CHAPTER 1 – Normal Indigenous Intestinal Flora (1983) (566)
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism (2000) (554)
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children (2004) (516)
Effect of diet on human fecal flora: comparison of Japanese and American diets. (1974) (511)
Susceptibility of Anaerobic Bacteria to 23 Antimicrobial Agents (1976) (427)
Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938. (2016) (423)
Legionnaires' Disease: Report of Sixty‐five Nosocomially Acquired Cases and Review of the Literature (1980) (335)
Anaerobic infections of the lung and pleural space. (2015) (315)
The bacteriology of aspiration pneumonia. (1974) (310)
Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov (2008) (277)
Sinus disease in children with respiratory allergy. (1978) (221)
Bacteriology of human and animal bite wounds (1978) (215)
Vasculitides associated with infections, immunization, and antimicrobial drugs. (1995) (205)
Bacteriology of empyema. (1974) (194)
The bacteriology of gangrenous and perforated appendicitis--revisited. (1990) (192)
Microbiology of regressive autism. (2012) (187)
Fecal microbial flora in Seventh Day Adventist populations and control subjects. (1977) (185)
Legionnaires' disease: clinical features of 24 cases. (1978) (183)
Rapid method that aids in distinguishing Gram-positive from Gram-negative anaerobic bacteria (1981) (182)
Desulfovibrio species are potentially important in regressive autism. (2011) (177)
Clinical aspects of bacteremia after manipulation of the genitourinary tract. (1973) (176)
Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. (2014) (164)
Multicenter Evaluation of the Cepheid Xpert Methicillin-Resistant Staphylococcus aureus (MRSA) Test as a Rapid Screening Method for Detection of MRSA in Nares (2009) (162)
d-Lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. (1982) (158)
Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates. (2015) (158)
Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. (1995) (155)
Anaerobic pleuropulmonary infections. (1972) (151)
Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. (1972) (151)
National Survey on the Susceptibility of Bacteroides fragilis Group: Report and Analysis of Trends in the United States from 1997 to 2004 (2007) (150)
BONE INFECTIONS INVOLVING ANAEROBIC BACTERIA (1978) (147)
Bacteriology of chronic otitis media. (1979) (146)
Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions (1982) (145)
Fecal bacteriology of colonic polyp patients and control patients. (1975) (145)
Anaerobic pyogenic liver abscess. (1971) (144)
Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). (2010) (142)
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation (1988) (140)
Bacterial interference between Clostridium difficile and normal fecal flora. (1981) (138)
Anaerobic Infections in Humans (1989) (133)
Deconjugation of bile acids by intestinal bacteria: review of literature and additional studies. (1969) (133)
Cetobacterium somerae sp. nov. from human feces and emended description of the genus Cetobacterium. (2003) (130)
Anaerobic infections in humans: an overview. (1995) (129)
Management of anaerobic infections. (1975) (128)
Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces. (1989) (121)
Effect of a partially chemically defined diet on normal human fecal flora. (1972) (120)
Aerobic and anaerobic bacterial flora of the maternal cervix and newborn gastric fluid and conjunctiva: a prospective study. (1979) (119)
In Vitro Activities of OPT-80 and Comparator Drugs against Intestinal Bacteria (2004) (118)
Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. (2002) (117)
Antibiotic disc susceptibility tests for rapid presumptive identification of Gram-negative anaerobic bacilli. (1971) (115)
Aspergillosis: A review and report of twelve cases (1959) (114)
State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. (2011) (113)
Therapy and epidemiology of autism--clostridial spores as key elements. (2008) (111)
ÆTIOLOGY OF ANTIMICROBIAL-AGENT-ASSOCIATED COLITIS (1978) (111)
Susceptibility of the Bacteroides fragilis group in the United States in 1981 (1983) (109)
Xylooligosaccharide supplementation alters gut bacteria in both healthy and prediabetic adults: a pilot study (2015) (108)
Treatment of Anaerobic Infections with Metronidazole (1975) (106)
Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. (2003) (105)
A retrospective review of cases of anaerobic empyema and update of bacteriology. (1995) (104)
Alistipes onderdonkii sp. nov. and Alistipes shahii sp. nov., of human origin. (2006) (103)
Treatment of anaerobic infections with lincomycin and clindamycin. (1972) (102)
Bacteriology and treatment of primary lung abscess. (2015) (101)
Fecal flora in different populations, with special reference to diet. (1978) (101)
LEGIONNAIRES' DISEASE IN RENAL-TRANSPLANT RECIPIENTS (1978) (100)
Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. (1978) (100)
A microbiological comparison between acute and complicated appendicitis. (1992) (99)
Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. (1975) (98)
Potable water as a source of Legionnaires' disease. (1985) (97)
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States (1985) (96)
Multicenter Study of In Vitro Susceptibility of theBacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996 (1999) (96)
BACTERIOLOGY OF ASPIRATION PNEUMONIA IN CHILDREN (1977) (95)
A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL. (1965) (95)
Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. (2000) (95)
Report of the ICSB Taxonomic Subcommittee on Gram-Negative Anaerobic Rods: Proposal That the Saccharolytic and Asaccharolytic Strains at Present Classified in the Species Bacteroides melaninogenicus (Oliver and Wherry) Be Reclassified in Two Species as Bacteroides melaninogenicus and Bacteroides asa (1977) (95)
NATIONAL SURVEY ON THE SUSCEPTIBILITY OF BACTEROIDES FRAGILIS GROUP: REPORT AND ANALYSIS OF TRENDS FOR 1997–2000 (2002) (93)
Immunologic diagnosis of Legionnaires' disease: cross-reactions with anaerobic and microaerophilic organisms and infections caused by them. (1980) (91)
Pomegranate extract induces ellagitannin metabolite formation and changes stool microbiota in healthy volunteers. (2015) (91)
Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. (1973) (91)
Bacteriology of rattlesnake venom and implications for therapy. (1979) (90)
Aetiology of antimicrobial-agent-associated colitis. (1978) (90)
Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. (2000) (89)
Bacteremia after genitourinary tract manipulation: bacteriological aspects and evaluation of various blood culture systems. (1972) (89)
Purification and characterization of Clostridium difficile toxin (1979) (89)
Endocarditis due to anaerobic gram-negative bacilli. (1973) (87)
The changing spectrum of nocardiosis. A review and presentation of nine cases. (1961) (87)
Aerobic and anaerobic bacteriology of cutaneous abscesses in children. (1981) (87)
Gangrenous and perforated appendicitis with peritonitis: treatment and bacteriology. (1990) (86)
Standardized Antimicrobial Disc Susceptibility Testing of Anaerobic Bacteria. I. Susceptibility of Bacteroides fragilis to Tetracycline (1972) (86)
16S Ribosomal DNA Sequence-Based Analysis of Clinically Significant Gram-Positive Anaerobic Cocci (2003) (85)
Antimicrobial agent-induced diarrhea--a bacterial disease. (1977) (85)
Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic Bacteria (1981) (85)
Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera. (1981) (83)
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982 (1984) (81)
Role of anaerobic bacteria in bite-wound infections. (1984) (79)
Pomegranate ellagitannins stimulate growth of gut bacteria in vitro: Implications for prebiotic and metabolic effects. (2015) (78)
Bacteriology and therapy of lung abscess in children. (1979) (78)
A New Rat Model Links Two Contemporary Theories in Irritable Bowel Syndrome (2008) (78)
Bypass enteropathy. Intestinal and systemic manifestations following small-bowel bypass. (1976) (78)
Legionnaires' disease: unusual clinical and laboratory features. (1980) (77)
Synovial fluid lactic acid. A diagnostic aid in septic arthritis. (1978) (77)
Dog bite wounds and infection: a prospective clinical study. (1980) (76)
Metronidazole versus anaerobes. In vitro data and initial clinical observations. (1972) (76)
Detection of Clostridium perfringens toxin genes in the gut microbiota of autistic children. (2017) (76)
PRACTICAL ASPECTS OF ANAEROBIC SEPSIS (1973) (74)
Anaerotruncus colihominis gen. nov., sp. nov., from human faeces. (2004) (73)
HAEMOPHILUS APHROPHILUS INFECTIONS: CLINICAL AND BACTERIOLOGIC STUDIES (1970) (73)
Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates. (1996) (72)
Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis. (1980) (70)
Emergence of fluoroquinolone resistance among Bacteroides species. (2003) (69)
The normal flora of ileostomy and transverse colostomy effluents. (1970) (69)
Brain abscess and cerebritis. (1984) (69)
The importance of black-pigmented gram-negative anaerobes in human infections. (1993) (69)
Clostridium bolteae sp. nov., isolated from human sources. (2003) (69)
Amikacin therapy for serious gram-negative bacillary infections. (1975) (69)
Clostridium clostridioforme: a mixture of three clinically important species (2005) (69)
Antibiotic Susceptibility Patterns as Aids in Classification and Characterization of Gram-negative Anaerobic Bacilli (1967) (67)
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species. (1980) (67)
In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp (2015) (66)
Overview of clinically important anaerobes. (1995) (66)
Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples. (2011) (66)
Comparison of methods for isolation of anaerobic bacteria from clinical specimens. (1973) (65)
Interaction of antimicrobial therapy and intestinal flora. (1970) (64)
Approaches to the study of the systematics of anaerobic, gram-negative, non-sporeforming rods: current status and perspectives. (2009) (63)
Treatment and prevention of antimicrobial agent-induced colitis and diarrhea (1980) (63)
Serine Lipids of Porphyromonas gingivalis Are Human and Mouse Toll-Like Receptor 2 Ligands (2013) (62)
Detection of Haemophilus aphrophilus in the human oral flora with a selective medium. (1972) (62)
ISOLATION OF LEGIONELLA PNEUMOPHILA FROM BLOOD (1979) (61)
Role of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in extraoral and some odontogenic infections. (1997) (59)
Peptoniphilus gorbachii sp. nov., Peptoniphilus olsenii sp. nov., and Anaerococcus murdochii sp. nov. Isolated from Clinical Specimens of Human Origin (2007) (59)
Present Status of Therapy for Anaerobic Infections (1996) (59)
Aerobic and anaerobic bacteriology of acute otitis media in children. (1978) (58)
Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. (1968) (57)
Bacteriology of anaerobic pleuropulmonary infections: preliminary report. (1993) (57)
Bailey and Scott's Diagnostic microbiology: A textbook for the isolation and identification of pathogenic microorganisms (1970) (56)
Anaerobic infections. Part II. (1985) (55)
Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection. (1987) (55)
Bypass enteropathy: an inflammatory process in the excluded segment with systemic complications. (1977) (54)
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria (1985) (54)
Joint infection by anaerobic bacteria: a case report and review of the literature. (1969) (54)
Bacteroides gracilis, an important anaerobic bacterial pathogen (1985) (54)
Peritonsillar abscess, retropharyngeal abscess, mediastinitis, and nonclostridial anaerobic myonecrosis: a case report. (1993) (54)
Impact of cefoperazone therapy on fecal flora (1982) (54)
NEW SELECTIVE AND DIFFERENTIAL MEDIUM FOR COAGULASE-POSITIVE STAPHYLOCOCCI ALLOWING RAPID GROWTH AND STRAIN DIFFERENTIATION (1961) (53)
Clostridium difficile : its role in intestinal disease (1988) (53)
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria (1996) (53)
TOXICITY OF KANAMYCIN IN ADULTS (1966) (52)
Standardized Antimicrobial Disc Susceptibility Testing of Anaerobic Bacteria: In Vitro Susceptibility of Clostridium perfringens to Nine Antibiotics (1972) (52)
Recently described clinically important anaerobic bacteria: medical aspects. (1997) (52)
Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections (1988) (51)
Practical aerobic membrane filtration blood culture technique: clinical blood culture trial (1975) (51)
Bacterial flora of the small bowel before and after bypass procedure for morbid obesity. (1978) (51)
Intestinal bacteria. The role they play in normal physiology, pathologic physiology, and infection. (1969) (51)
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987. (1990) (50)
Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy (1984) (50)
Treatment and long-term follow-up of foot infections in patients with diabetes or ischemia: a randomized, prospective, double-blind comparison of cefoxitin and ceftizoxime. (1987) (50)
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. (1996) (50)
“Bacteroides nordii” sp. nov. and “Bacteroides salyersae” sp. nov. Isolated from Clinical Specimens of Human Intestinal Origin (2004) (49)
Pomegranate ellagitannins stimulate the growth of Akkermansia muciniphila in vivo. (2017) (49)
CHAPTER 16 – Changes in Human Intestinal Flora Related to the Administration of Antimicrobial Agents (1983) (48)
Anaerobes: problems and controversies in bacteriology, infections, and susceptibility testing. (1990) (48)
β-Lactamase Production in Prevotella intermedia,Prevotella nigrescens, and Prevotella pallensGenotypes and In Vitro Susceptibilities to Selected Antimicrobial Agents (1999) (48)
“Bacteroides goldsteinii sp. nov.” Isolated from Clinical Specimens of Human Intestinal Origin (2005) (48)
Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group (1990) (47)
Susceptibility testing of anaerobic bacteria (1988) (47)
Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens (1979) (47)
Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. (2012) (47)
Comparison of Selective Media for Isolation of Presumptive Group D Streptococci from Human Feces (1971) (47)
Phosphorylated Dihydroceramides from Common Human Bacteria Are Recovered in Human Tissues (2011) (46)
Prebiotic Potential and Chemical Composition of Seven Culinary Spice Extracts (2017) (46)
Contamination of a hospital environment byClostridium difficile (1979) (46)
In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms (2002) (45)
The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. (1974) (45)
Diarrhea and colitis associated with antimicrobial therapy in man and animals. (1979) (44)
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis (1982) (44)
A study of 23 cases of Reiter's syndrome. (1953) (44)
Susceptibility of Respiratory Tract Anaerobes to Orally Administered Penicillins and Cephalosporins (1976) (43)
Intestinal beta-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis. (1983) (43)
Combined screw-cap and rubber-stopper closure for Hungate tubes (pre-reduced anaerobically sterilized roll tubes and liquid media). (1969) (43)
Antimicrobial resistance in Bacteroides. (1987) (43)
Inactivation of anaerobic bacteria by various photosensitized porphyrins or by hemin (1994) (43)
Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity (1981) (42)
Porphyromonas somerae sp. nov., a Pathogen Isolated from Humans and Distinct from Porphyromonas levii (2005) (42)
Comparison of three procedures for biochemical testing of anaerobic bacteria (1975) (42)
Characterization of Slackia exigua Isolated from Human Wound Infections, Including Abscesses of Intestinal Origin (2010) (42)
Cefoxitin: Clinical Evaluation in Thirty-Eight Patients (1977) (41)
Study of the In Vitro Activities of Rifaximin and Comparator Agents against 536 Anaerobic Intestinal Bacteria from the Perspective of Potential Utility in Pathology Involving Bowel Flora (2008) (41)
Bilophila wadsworthia isolates from clinical specimens (1992) (41)
Evaluation of 16S rRNA Sequencing and Reevaluation of a Short Biochemical Scheme for Identification of Clinically Significant Bacteroides Species (2005) (41)
A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatment. (1976) (41)
Fastidiosipila sanguinis gen. nov., sp. nov., a new Gram-positive, coccus-shaped organism from human blood. (2005) (41)
Bacteraemia caused by Anaerotruncus colihominis and emended description of the species (2006) (40)
Acute suppurative parotitis caused by anaerobic bacteria: report of two cases. (1978) (40)
New markers for Eubacterium lentum (1979) (39)
Cephalothin in serious bacterial infection. (1966) (39)
Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy (1986) (39)
Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis. (2015) (39)
Host factors predisposing to anaerobic infections. (1993) (39)
Anaerobic and aerobic bacteriology of acute conjunctivitis. (1979) (38)
Clostridium bartlettii sp. nov., isolated from human faeces. (2004) (38)
Lincomycin: activity against anaerobes and effect on normal human fecal flora. (1965) (38)
Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria (1991) (38)
Anaerobic and aerobic bacteriology in head and neck cancer surgery. (1977) (38)
Pericardial actinomycosis: case report and review. (1991) (37)
Comparative in vitro activity of ceftriaxone against anaerobic bacteria (1982) (37)
Susceptibility of Clostridium septicum to 23 Antimicrobial Agents (1981) (37)
Activity of combinations of antimicrobial agents against Bacteroides fragilis. (1976) (37)
Antibacterial Sensitivity of Bifidobacterium (Lactobacillus bifidus) (1967) (36)
Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum. (1995) (36)
Porphyromonas uenonis sp. nov., a Pathogen for Humans Distinct from P. asaccharolytica and P. endodontalis (2004) (36)
Susceptibility of Eikenella corrodens to Ten Cephalosporins (1978) (36)
Detection of Porphyromonas gulae from subgingival biofilms of dogs with and without periodontitis. (2011) (36)
Reclassification of Ruminococcus obeum as Blautia obeum comb. nov. (2015) (36)
Legionnaires' disease--still with us. (1988) (35)
Comparative Susceptibilities of Anaerobic Bacteria to Metronidazole, Ornidazole, and SC-28538 (1978) (35)
Sources and antimicrobial susceptibilities of Campylobacter gracilis and Sutterella wadsworthensis. (1997) (35)
DIPHTHEROID ENDOCARDITIS AFTER CARDIOPULMONARY BYPASS SURGERY FOR THE REPAIR OF CARDIAC VALVULAR DEFECTS. (1963) (35)
Taxonomy--General comments and update on taxonomy of Clostridia and Anaerobic cocci. (2002) (34)
Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. (2000) (34)
Antimicrobial susceptibility testing of Bilophila wadsworthia by using triphenyltetrazolium chloride to facilitate endpoint determination (1992) (34)
In vitro activities of three of the newer quinolones against anaerobic bacteria (1992) (33)
Serious infection with Leptotrichia buccalis. Report of a case and review of the literature. (1980) (33)
Bilophila wadsworthia isolates from clinical specimens. (1995) (33)
Murdochiella asaccharolytica gen. nov., sp. nov., a Gram-stain-positive, anaerobic coccus isolated from human wound specimens. (2010) (33)
Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology (1990) (33)
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin (1983) (33)
Fatal septicemia due to Clostridium hathewayi and Campylobacter hominis. (2005) (33)
Quantitative Detection of Enterotoxigenic Bacteroides fragilis Subtypes Isolated from Children with and without Diarrhea (2010) (32)
Therapy for infections due to anaerobic bacteria: an overview. (1977) (32)
Enterocolitis due to phage type 54 staphylococci resistant to kanamycin, neomycin, paromomycin and chloramphenicol. (1960) (32)
Polyacrylamide gel electrophoresis patterns produced by Clostridium difficile. (1984) (31)
Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor (1987) (31)
In Vitro Activities of Faropenem against 579 Strains of Anaerobic Bacteria (2002) (31)
Rapid identification of Gram-positive anaerobic coccal species originally classified in the genus Peptostreptococcus by multiplex PCR assays using genus- and species-specific primers. (2003) (31)
Effect of bile and desoxycholate on gram-negative anaerobic bacteria. (1970) (30)
Listeria monocytogenes meningitis; summation of literature and report of two new cases. (1954) (30)
Practical aerobic membrane filtration blood culture technique: development of procedure (1975) (30)
Susceptibility testing of anaerobic bacteria. (1983) (30)
Human rabies transmitted by the bite of a bat: with comments on the duck-embryo vaccine. (1960) (29)
Comparison of liquid growth media for Legionella pneumophila (1981) (29)
Evaluation of genotypic and phenotypic methods for differentiation of the members of the Anginosus group streptococci (2009) (29)
NEUTROPENIC REACTION TO CEPHALOTHIN THERAPY. (1963) (29)
39 – Therapy of Anaerobic Infections (1989) (28)
In vitro activity of ramoplanin and comparator drugs against anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora. (2004) (28)
Nonsporulating anaerobic bacteria in osteomyelitis. (1967) (28)
In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria (1988) (28)
Anaerofustis stercorihominis gen. nov., sp. nov., from human feces. (2004) (28)
Cellular fatty acid composition, soluble-protein profile, and antimicrobial resistance pattern of Eubacterium lentum. (1998) (28)
In Vitro Activity of Levofloxacin against a Selected Group of Anaerobic Bacteria Isolated from Skin and Soft Tissue Infections (1998) (28)
Survival of anaerobes in original specimens transported by overnight mail services. (1995) (28)
Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation (1996) (28)
Clinical evaluation of moxalactam (1982) (28)
Use of 16S-23S rRNA spacer-region (SR)-PCR for identification of intestinal clostridia. (2002) (27)
Pomegranate extract exhibits in vitro activity against Clostridium difficile. (2014) (27)
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria (1991) (27)
Susceptibility of gram-negative anaerobic bacilli to gentamicin and other aminoglycosides. (1971) (27)
Disk Susceptibility Testing of Slow-Growing Anaerobic Bacteria (1975) (27)
ISOLATION OF A NEW SEROTYPE OF LEGIONNAIRES' DISEASE BACTERIUM (1978) (27)
Deposition and hydrolysis of serine dipeptide lipids of Bacteroidetes bacteria in human arteries: relationship to atherosclerosis (2017) (27)
Lower respiratory tract infection. (1985) (27)
In vitro activity of cefotetan compared with that of other antimicrobial agents against anaerobic bacteria (1988) (26)
Impact of imipenem/cilastatin therapy on normal fecal flora. (1985) (26)
In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins. (1982) (26)
New medium selective for Fusobacterium species and differential for Fusobacterium necrophorum (1981) (26)
Isolation of Legionella pneumophila from hospital potable water specimens: comparison of direct plating with guinea pig inoculation (1982) (26)
Infections following clenched-fist injury: a new perspective. (1978) (26)
Anaerobes in burn-wound infections. (1984) (26)
Rapid diagnosis of bacteremia with quantitative differential-membrane filtration culture. (1966) (26)
In vitro efficacy of β-lactam/β-lactamase inhibitor combinations against bacteria involved in mixed infections (1999) (26)
Clinical importance of Bilophila wadsworthia. (1992) (25)
Aspiration pneumonia. (1991) (25)
In vitro activity of DU-6859a against anaerobic bacteria (1994) (25)
A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections. (1986) (25)
Ticarcillin/Clavulanate versus Imipenem/Cilistatin for the Treatment of Infections Associated with Gangrenous and Perforated Appendicitis (1999) (25)
A simple, rapid method to process and assay fatty acids and alcohols by gas chromatography. (1973) (25)
Evaluation of polyanethol sulfonate (liquoid) in blood cultures. (1967) (25)
Anaerobic Gram-Negative Bacilli (1996) (25)
Peptoniphilus duerdenii sp. nov. and Peptoniphilus koenoeneniae sp. nov., isolated from human clinical specimens. (2012) (24)
Rosamicin: In Vitro Activity Against Anaerobes and Comparison with Erythromycin (1976) (24)
Cell-wall-defective variants of Fusobacterium (1989) (24)
Infectious diseases 1979--antimicrobial agent-induced colitis: an update. (1979) (24)
Determination of bft Gene Subtypes in Bacteroides fragilis Clinical Isolates (2007) (24)
Long-term followup of two patients with pulmonary cavitation caused by Legionella pneumophila. (1981) (24)
Comparison of recovery of anaerobic bacteria using the Anoxomat, anaerobic chamber, and GasPak jar systems. (1999) (24)
Development of a Flow Chart for Identification of Gram-Positive Anaerobic Cocci in the Clinical Laboratory (2006) (24)
Porphyromonas bennonis sp. nov., isolated from human clinical specimens. (2009) (24)
Mechanisms of resistance in anaerobes and new developments in testing. (1989) (24)
Intravenous metronidazole for treatment of infections involving anaerobic bacteria (1982) (24)
Isolation of Acidaminococcus fermentans and Megasphaera elsdenii from normal human feces. (1974) (23)
Intra-abdominal infection (1981) (23)
The intraocular environment and experimental anaerobic bacterial endophthalmitis. (1987) (23)
In vitro activity of imipenem against anaerobic bacteria. (1985) (23)
Problems encountered in clinical anaerobic bacteriology. (1984) (23)
Biochemical and genetic characterization of a Prevotella intermedia/nigrescens-like organism. (1998) (22)
Bacterial agglutination and polyacrylamide gel electrophoresis for typing Clostridium difficile. (1986) (22)
Nontraumatic clostridial myonecrosis: an infectious disease emergency. (1981) (21)
Phenotypic and Molecular Characterization of Solobacterium moorei Isolates from Patients with Wound Infection (2010) (21)
Urease and deaminase activities of fecal bacteria in hepatic coma. (1970) (21)
Characteristics of an unusual anaerobic pigmented gram-negative rod isolated from normal and inflamed appendices. (1997) (21)
Susceptibility of isolates of Bacteroides to the bactericidal activity of normal human serum. (1979) (21)
Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin (1981) (20)
Characterization of bacteroides melaninogenicus (1976) (20)
A primer on anaerobic bacteria and anaerobic infections for the uninitiated (1999) (20)
Cellular Fatty Acid Analysis and Enzyme Profiles ofPorphyromonas catoniae— a Frequent Colonizer of the Oral Cavity in Children (1996) (19)
Aerobic and anaerobic flora in bladder urine of patients with indwelling urethral catheters. (1976) (19)
Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study. (1993) (19)
LABORATORY STUDIES WITH KANAMYCIN (1958) (19)
Preliminary study using species-specific oligonucleotide probe for rRNA of Bilophila wadsworthia (1994) (19)
Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species (1990) (19)
Current susceptibility patterns of anaerobic bacteria. (1998) (19)
In Vitro Activities of MK-826 (L-749,345) against 363 Strains of Anaerobic Bacteria (2000) (19)
8 – General Aspects of Anaerobic Infection (1989) (19)
Amikacin therapy for gram-negative septicemia. (1977) (18)
Cellular fatty acids in Fusobacterium species as a tool for identification (1992) (18)
Laboratory diagnosis of Legionnaires' disease. (1980) (18)
Isolation of Legionella pneumophila from a transtracheal aspirate (1979) (18)
Antimicrobial therapy of anaerobic infections: a status report. (1979) (18)
Perspective on susceptibility testing of anaerobic bacteria. (1997) (18)
Clostridium tertium isolated from gas gangrene wound; misidentified as Lactobacillus spp initially due to aerotolerant feature. (2007) (18)
Intestinal microbial changes and disease as a result of antimicrobial use (1986) (17)
Anaerobic bacteria. Their role in infection and their management. (1987) (17)
Clinical importance ofBilophila wadsworthia (1992) (17)
In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria (1994) (17)
Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity. (1987) (17)
Sinus infection due to Eikenella corrodens. (1978) (17)
Erythromycin for anaerobic pleuropulmonary and soft-tissue infections. (1979) (17)
Cefoxitin for treatment of infections due to anaerobic bacteria. (1979) (17)
Present studies of therapy for anaerobic infections. (1996) (17)
Preliminary evidence of endotoxic activity of Bilophila wadsworthia. (1995) (17)
HUMAN BITE INFECTIONS (1977) (17)
Normal human intestinal flora. (1986) (17)
Pathogenic anaerobes. (1982) (17)
Nalidixic acid: clinical and laboratory studies. (1966) (16)
Corynebacterium pyruviciproducens sp. nov., a pyruvic acid producer. (2010) (16)
Anaerobic infections: diagnosis and treatment. (1976) (16)
Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis. (1986) (16)
Chronic anaerobic bacterial endophthalmitis in pseudophakic rabbit eyes. (1987) (16)
Anaerobic prostatic abscess with bacteremia. (1973) (16)
Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint. (1985) (16)
Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and Other Anaerobic Cocci (2015) (16)
Effect of silver nitrate application on the conjunctival flora of the newborn: and the occurrence of clostridial conjunctivitis. (1978) (16)
Anaerobic infections. Part I. (1985) (16)
Isolation of a Strictly Anaerobic Strain of Staphylococcus epidermidis (2006) (16)
Late infection in patients with Starr-Edwards prosthetic cardiac valves. (1965) (15)
CHRONIC PULMONARY CRYPTOCOCCOSIS. (1965) (15)
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. (1994) (15)
Susceptibility of anaerobes to cefoxitin sodium and cephalothin. (1978) (15)
In vitro activity of Bay Y3118 against anaerobic bacteria (1993) (15)
Isolation of Eikenella corrodens from pulmonary infections. (1979) (15)
Antimicrobial therapy of anaerobic infections. (1975) (15)
Studies on antibiotics and the normal intestinal flora. (1951) (15)
Normal human intestinal flora. (1986) (15)
Improved method for assay of formic acid by gas-liquid chromatography (1978) (15)
Enzymatic profiles of Prevotella, Porphyromonas, and Bacteroides species obtained with the API ZYM system and Rosco diagnostic tablets. (1995) (15)
Evaluation of the sodium polyanethol sulfonate disk test for the identification of Peptostreptococcus anaerobius (1976) (15)
In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial Isolates (2009) (15)
Biochemical and polyacrylamide gel electrophoretic analyses of vaginosis-associated anaerobic curved rods. (1984) (15)
A century of anaerobes: a look backward and a call to arms. (1993) (15)
Propionibacterium acnes isolated from explanted intraocular lens in pseudophakic bullous keratopathy. (1989) (14)
Bacterial infections of the lung. (1982) (14)
Toxigenicity and antimicrobial susceptibility ofClostridium difficile, a cause of antimicrobial agent-associated colitis (2007) (14)
Bacteriology of tracheal aspirates in intubated newborn. (1980) (14)
Scope monograph on anaerobic infections (1972) (14)
Taxonomy, enzymes, and clinical relevance of anaerobic bacteria. (1979) (13)
Rapid β-lactamase testing in bacteroides (1981) (13)
Gangrenous and/or perforated appendix: clinical outcome and in vitro susceptibility testing. (1990) (13)
Innate immune recognition of, and response to, Clostridium sordellii. (2010) (13)
In vitro Activity of Moxifloxacin Against 179 Strains of Anaerobic Bacteria Found in Pulmonary Infections (2000) (13)
Airborne bacterial contamination of operative wounds. (1976) (13)
In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections. (1999) (13)
Transformation of 4-androsten-3,17-dione by growing cultures and cell extracts of Clostridium paraputrificum. (1979) (13)
Incidence of side effects and changes in fecal microflora following administration of tetracycline and tetracycline-nystatin. (1955) (13)
Antigenic distinctiveness of Mobiluncus curtisii and Mobiluncus mulieris (1985) (13)
In vitro Activity of Gatifloxacin Against 238 Strains of Anaerobic Bacteria (2001) (13)
Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis. (2015) (13)
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria. (2001) (13)
Ultrastructure and molecular characterization of Fusobacterium necrophorum biovars. (1992) (13)
Rifampin-Blood-Agar as a Selective Medium for the Isolation of Certain Anaerobic Bacteria (1971) (13)
A miniature anaerobic jar for tissue transport or for cultivation of anaerobes. (1970) (13)
Oligonucleotide probes to the 16S ribosomal RNA: implications of sequence homology and secondary structure with particular reference to the oral species Prevotella intermedia and Prevotella nigrescens. (2008) (12)
Gemella asaccharolytica sp. nov., isolated from human clinical specimens. (2010) (12)
Statistical analysis of the effects of trial, reader, and replicates on MIC determination for cefoxitin (1990) (12)
Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy. (1986) (12)
Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract. (1981) (12)
Infections due to anaerobes. (1968) (12)
Lincomycin: activity against anaerobes and effect on normal human fecal flora. (1965) (11)
206. Sinusitis in children with respiratory allergy (1978) (11)
Cellular Fatty Acid Composition, Soluble-Protein Profile, and Antimicrobial Resistance Pattern ofEubacterium lentum (1998) (11)
Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar media. (2002) (11)
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study. (1991) (11)
Genes Encoding Toxin of Clostridium difficile in Children with and without Diarrhea (2014) (11)
Current perspectives on anaerobic infections: diagnostic approaches. (1993) (11)
Doxycycline in abdominal surgery. (1977) (10)
Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria (1984) (10)
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989. (1992) (10)
In vitro activities of 17 antimicrobial agents against the formate/fumarate-requiring, anaerobic gram-negative bacilli. (1986) (10)
The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. (1974) (10)
Morphological response of Bilophila wadsworthia to imipenem: correlation with properties of penicillin-binding proteins (1993) (10)
High-performance liquid chromatographic assay for measurement of cefoxitin in serum. (1980) (10)
Six-year retrospective survey of the resistance of Bacteroides fragilis group species to clindamycin and cefoxitin. (1986) (10)
USE OF KANAMYCIN OR URINARY ACIDIFICATION FOR PROPHYLACTIC CHEMOTHERAPY IN TRANSURETHRAL PROSTATECTOMY (1966) (10)
Abnormalities in synovial fluid of patients with septic arthritis detected by gas-liquid chromatography. (1980) (10)
Serious infectious complications after flexible fiberoptic bronchoscopy. (1979) (10)
In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria. (1979) (10)
Anaerobic bacterial endophthalmitis in the rabbit. (1986) (10)
Legionnaires' disease. (1980) (10)
Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media. (2002) (10)
2 – Classification and Taxonomy of Anaerobes (1989) (10)
Laboratory diagnosis of anaerobic infections. (1976) (10)
Rapid presumptive bacteriological diagnosis of Legionnaires disease (1979) (9)
Comparison of the Accu-CulShure system and a swab placed in a B-D Port-a-Cul tube for specimen collection and transport. (1993) (9)
Infections due to anaerobes. (1968) (9)
The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin. (1979) (9)
Antibiotic sensitivity pattern of Bacteroides species. (1955) (9)
Chapter 17 – Therapy Directed against Clostridium difficile and Its Toxins: Complications of Therapy (1988) (9)
A rat model of unilateral utero-tubo-ovarian abscess. (1984) (9)
Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy. (1986) (9)
In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria. (1994) (9)
Porphyromonas endodontalis-like organisms from extraoral sources. (1997) (9)
The role of anaerobes in human infections. (1981) (9)
Propionibacterium acnes-enhanced lens-induced granulomatous uveitis in the rat. (1992) (8)
Adherence of Bilophila wadsworthia to cultured human embryonic intestinal cells. (1998) (8)
Rapid Diagnosis of Bacteremia (1969) (8)
Rapid diagnosis of bacteremia. (1970) (8)
Bacteriologic and clinical study of Bacteroides oris and Bacteroides buccae (1987) (8)
Anaerobic Infections in Otolaryngology (1981) (8)
Necrotizing pneumonitis and empyema due to microaerophilic streptococci. (1965) (8)
In Vitro Activities of DX-619 and Four Comparator Agents against 376 Anaerobic Bacterial Isolates (2006) (8)
Inhibitory interactions between normal fecal flora and Clostridium difficile (1980) (8)
Clinical features and diagnosis of anaerobic pleuropulmonary infections. (1970) (8)
Corynebacterium pyruviciproducens promotes the production of ovalbumin specific antibody via stimulating dendritic cell differentiation and up-regulating Th2 biased immune response. (2012) (8)
Characterization of Bilophila wadsworthia Isolates Using PCR Fingerprinting (1999) (8)
Anaerobes in biliary tract infection. (1979) (8)
Anaerobic and aerobic bacteriology in head and neck cancer surgery. (1978) (8)
Bacteroides levii-like organisms isolated from clinical specimens. (1995) (8)
Anaerobic pleuropulmonary infection. (1990) (8)
In vitro activity of HMR 3004 (RU 64004) against 502 strains of anaerobic bacteria (1999) (7)
Failure to detect Clostridium difficile in foods. (1983) (7)
Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniques. (1988) (7)
UV red fluorescence of Eubacterium lentum (1993) (7)
Cefoxitin sodium therapy of anaerobic infections. (1978) (7)
Legionnaires' disease in the postoperative patient. (1981) (7)
Mobilization and prevalence of a Fusobacterial plasmid. (2010) (7)
Combined Screw-Cap and Rubber-Stopper Closure for Hungate Tubes (Pre-reduced Anaerobically Sterilized Roll Tubes and Liquid Media) (1969) (7)
A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections. (1989) (6)
The role of anaerobes in human infections. (1981) (6)
Rapid beta-lactamase testing in bacteroides. (1981) (6)
Laboratory Diagnosis of Legionnaires' Disease1–4 (2015) (6)
Clinical evaluation of kanamycin. (1958) (6)
In vitro activity of selected antibiotics against anaerobes. (1987) (6)
In vitro activity of cefbuperazone against anaerobic bacteria (1985) (6)
A prospective double-blind comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing intra-abdominal operations. (1985) (6)
Anaerobic bacteria: their recognition and significance in the clinical laboratory. (1973) (5)
Selective medium for isolation of Bacteroides gracilis (1990) (5)
On Assuming the Editorship of Reviews of Infectious Diseases (1990) (5)
Useofa Semiselective MediumtoCulture Legionella pneumophila fromContaminated LungSpecimens (1979) (5)
Antimicrobial therapy for anaerobic infections. (1984) (5)
Sulfonamides, nitrofurans and nalidixic acid. (1968) (5)
In-vitro susceptibilities of Bacteroides gracilis, Fusobacterium mortiferum and F. varium to 17 antimicrobial agents. (1990) (5)
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group. (1991) (5)
Susceptibility of anaerobic bacteria to Sch 29482. (1982) (5)
Anaerobic Infections: Diagnosis and Treatment (1976) (5)
Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains. (1989) (5)
Review of early research on anaerobes. (1994) (5)
IN VITRO SENSITIVITY TO NITROFURANTOIN COMPARED WITH CLINICAL BACTERIOLOGICAL RESPONSE. (1964) (5)
FÆCAL CHOLESTEROL CONVERSION AND POLYP STATUS (1976) (5)
Role of Anaerobic Bacteria in Infections of the Tonsils and Adenoids (1991) (5)
Antibiotic sensitivity pattern of Bacteroides species. (1955) (4)
Anaerobic pulmonary infection. (1989) (4)
Anaerobic infections. (1979) (4)
Nitrofurantoin: additional studies comparing in vitro drug susceptibility with clinical bacteriological response. (1966) (4)
Anaerobic infections of the abdomen and pelvis. (1975) (4)
Clinical experience with dimethoxyphenyl penicillin. (1962) (4)
Operations on the colon. The role of antibiotics in preoperative preparation. (1965) (4)
Amikacin therapy of serious gram-negative bacillary infections in chronic hemodialysis patients. (1978) (4)
Treatment of anaerobic infections: an overview. (1985) (4)
Treatment and prevention of antimicrobial agent-induced colitis and diarrhae. (1980) (4)
Absence of relationship of fecal Clostridium perfringens to rheumatoid arthritis and rheumatoid variants. (1973) (4)
In vitro susceptibility of proteus to antibiotic agents (1955) (4)
Changes in taxonomy, anaerobes associated with humans, 2001-2004. (2004) (4)
In vitro activity of selected antibiotics against anaerobes. (1987) (4)
Hands on the heart: palpation of the cardiovascular system. (1989) (3)
Isolation of Acidaminococcus fermentans and Megasphaera elsdenii from Normal Human Feces (1974) (3)
Gastrointestinal Infection with Campylobacter jejuni 81–176 Produces Altered Bowel Function and Bacterial Overgrowth in Rats: 1216 (2006) (3)
In-vitro activity of Sch 34343 against anaerobic bacteria. (1985) (3)
Antibiotic Disc Susceptibility Tests for Rapid Presumptive Identification of Gram-Negative Anaerobic Bacilli (1971) (3)
Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria (1987) (3)
Infections due to non-sporeforming anaerobic bacteria. (1970) (3)
Bacteremia After Genitourinary Tract Manipulation: Bacteriological Aspects and Evaluation of Various Blood Culture Systems (1972) (3)
Chemotherapy guide. (1969) (3)
The in-vitro activity of L-627 against anaerobic bacteria. (1994) (3)
Xylooligosaccharide Induced Changes in Gut Microbiota in Healthy and Prediabetic Adults (2015) (3)
Pasteur: The Anaerobic Life and the Anaerobes (1995) (3)
A little kid from Far Rockaway grows up (2012) (3)
Comparison ofMethodsforIsolation of Anaerobic Bacteria fromClinical Specimens (1973) (3)
Metronidazole : proceedings of the International Metronidazole Conference Montreal, Quebec, Canada, May 26-28, 1976 (1977) (3)
Introduction: changing patterns of hospital infections: implications for therapy. (1984) (3)
The significance of the intestinal microflora. (1970) (3)
Anaerobic infections: a clinical overview. (2002) (3)
Anaerobic pleuropulmonary infections. Clinical considerations. (1975) (3)
CONTROLLED EVALUATION OF ENVIRONMENTAL DECONTAMINATION OF GENERAL SURGICAL WARDS. (1963) (3)
Centennial symposium on anaerobes: a memorial to André Veillon. The secret pathogens. Introduction. (1994) (3)
Photomicrography of bacterial colonies in rool tubes. (1969) (2)
Immunoblot typing of Bacteroides gracilis. (1995) (2)
Comparative Susceptibilities ofAnaerobic Bacteria to Metronidazole, Ornidazole, andSC-28538 (1978) (2)
Xylooligosaccharide increases bifidobacteria but not lactobacilli demonstrating potential for obesity prevention and treatment (37.6) (2014) (2)
InVitro Activity ofCefbuperazone Against Anaerobic Bacteria (1985) (2)
Laboratory diagnosis of anaerobic infections. (1976) (2)
Operations on the colon. The role of antibiotics in preoperative preparation. (1965) (2)
Eikenella corrodens and pulmonary infections. (1979) (2)
1994 Referees (2004) (2)
Effects of differences in media and methods on MIC values for anaerobes. (1990) (2)
Factors affecting studies with chemically defined diets. (1973) (2)
Fecal Bacterial Flora and Clindamycin-Associated Colitis (1976) (2)
Isolation of Eikenella corrodens from Pulmonary Infections1, 2 (2015) (2)
Infections due to non-sporeforming anaerobic bacteria. (1970) (2)
Bacteriology of Infected, Subcutaneous Tissue in Diffuse Cellulitis and Foot Ulcer Infections in Patients with Diabetes Mellitus using Cultures and Molecular Identification Techniques (2015) (2)
In memoriam: Vera La Verne Sutter. (1991) (2)
EMERGEncy ID NET: Review of a 20-Year Multisite Emergency Department Emerging Infections Research Network (2017) (2)
Nude Mice Are Susceptible to Guinea Pig Passaged Legionella pneumophila1 (1984) (1)
Aerobic and Anaerobic Bacterial Flora of the Maternal Cervix and Newborn Gastric Fluid and Conjunctiva: A Prospective Study (1979) (1)
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group. (1990) (1)
In Vitro Activities of Newer Quinolones against Bacteroides Group Organisms (2003) (1)
Antimicrobial therapy for anaerobic infections. (1984) (1)
Proceedings of the North American Metronidazole Symposium. Anaerobic infections. Scottsdale, Arizona, October 7-9, 1981. Introduction. (1983) (1)
Anaerobic Bacterial Infections (Non-Spore-Forming) (1988) (1)
Rapid identi¢cation of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-speci¢c primers (2003) (1)
Letter: Fecal bacterial flora and clindamycin-associated colitis. (1976) (1)
Antibiotics and antibacterials, general. (1969) (1)
Animal Bites (1985) (1)
Vinblastine sulfate (NSC-49842) in the treatment of bronchogenic carcinoma. (1970) (1)
Response to Maja Rupnik. (2016) (1)
Anaerobic infections of the abdomen and pelvis. (1975) (1)
Clostridia in the Human Gastrointestinal Flora (2018) (1)
Anaerobic bacteria: their recognition and significance in the clinical laboratory. (1973) (1)
Letter: Treatment of anaerobic infections. (1974) (1)
The significance of the intestinal microflora. (1970) (1)
Clostridial Myconecrosis (Gas Gangrene) (1988) (1)
Letter: Treatment of anaerobic infections. (1974) (1)
Lung abscess. (1976) (1)
Miscellaneous Clostridial Infections (1988) (1)
Rapid methods: Overview and prospects for the future (1985) (1)
Gastrointestinal Microbiology in the Normal Host (2009) (1)
Serum penicillin concentration following oral administration of penicillin V. (1955) (1)
Proceedings of the North American Metronidazole Symposium. Anaerobic infections. Scottsdale, Arizona, October 7-9, 1981. (1983) (1)
[A laboratory and clinical trial of the combined preparation ampicillin/sulbactam]. (1991) (1)
A Special Message from the Editor (1995) (1)
Penicillin-Binding Proteins inFusobacteriumSpecies (1996) (1)
Activity of ABT-773 Against Bowel Flora Organisms (2002) (1)
Comparative activity of SCH 34343 against anaerobic bacteria. (1986) (1)
Differentiation of Bacteroides gracilis, Bacteroides gracilis-like organisms, and Campylobacter species on the basis of dehydrogenase patterns. (1995) (1)
Clinical relevance of antimicrobial susceptibility testing (1992) (1)
Activities of ABT-773 against Microaerophilic and Fastidious Organisms (2002) (1)
Comparison ofInVitro Antibiograms ofBacteroides fragilis Group Isolates: Differences inResistance RatesinTwoInstitutions because ofDifferences inSusceptibility Testing Methodology (1990) (0)
Statistical Analysis oftheEffects ofTrial, Reader, andReplicates on MICDetermination forCefoxitin (1990) (0)
An Antibiotics Control Program in a Large Teaching Hospital (1963) (0)
Formation of Urolithins in Normal Volunteers Following Pomegranate Extract Consumption for 28 Days is Associated with Differences in the Gut Microflora Population (2015) (0)
Morphological Response ofBilophila wadsworthia to Imipenem: Correlation withProperties of Penicillin-Bindi ng (1993) (0)
Single nucleotide polymorphisms are randomly dispersed and mostly synonymous in partial rpoB and cpn60 genes of Campylobacter showae human isolates. (2012) (0)
Abnormalities insynovial fluid ofpatients with septic arthritis detected bygas-liquid chromatography (1980) (0)
Colonic and inflammatory bowel diseases. (1975) (0)
Editorial: Past, Present, and Future of Infectious Diseases Society of America Publications (1998) (0)
Inoculating loop for anaerobic roll tubes, pre-reduced anaerobically sterilized (PRAS) liquid media and routine microbiological procedures1 (1970) (0)
Photomicrography of bacterial colonies in rool tubes. (1969) (0)
Microbiological considerations: Importance of anaerobes in obstetric and gynaecological infections (1986) (0)
Standardized Antimicrobial DiscSusceptibility Testing ofAnaerobic Bacteria: InVitro Susceptibility ofClostridium perfringens (1972) (0)
Rapid Identification of Key Pathogens in Wound Infection by Molecular Means (2006) (0)
Sa2016 Translocation of Enteric Bacteria, Colonic Dismotility and Altered Behavior in Blast-Type Traumatic Brain Injury in Rats (2015) (0)
Media- and method-dependent variation in MIC values of ceftizoxime for clinical isolates of the Bacteroides fragilis group. (1991) (0)
Treatment of Anaerobic Pleuropulmonary and Soft-Tissue Infections-Reply (1980) (0)
In vitro testing of Today vaginal contraceptive sponge with bacteria. (1986) (0)
DiskSusceptibility Testing ofSlow-Growing (1975) (0)
Third Antibiotics Symposium (1956) (0)
Clinical Infectious Disease: Anaerobic infections (2015) (0)
[A laboratory and clinical trial of the combined preparation ampicillin/sulbactam]. (1991) (0)
and apalcillin against anaerobic bacteria. Comparative in vitro activities of cefpiramide (2013) (0)
RECOLLECTIONS OF AN EARLY ANAEROBIST (1999) (0)
In Vitro Data and Initial Clinical Observations (2006) (0)
The Changing Spectrum of Nocardiosis1, 2, 3 (2015) (0)
In Vitro Efficacy of Sulbactam Combined with Ampicillin against Anaerobic Bacteria (1986) (0)
Successful Management of Severe Paraquat Poisoning (2017) (0)
Bronchopulmonary Geotrichosis1, 2 (2015) (0)
Summary of clinical aspects (1983) (0)
Determined byStandardized Antimicrobial Disc Susceptibility Testing (1973) (0)
Auditory nerve toxicity of dihydrostreptomycin sulfate and dihydrostreptomycin pantothenate. (1957) (0)
Infections Due to Bacteroides and Fusobacterium: Findings in 102 Patients. (1962) (0)
Propionibacferium Acnes-Enhanced Lens-Induced Granulomatous Uveifis in the Rat (2005) (0)
Bronchopulmonary geotrichosis. (1973) (0)
Enumeration and differential plate counting of microbial colonies by a stereoscopic microscope pattern cover method. (1968) (0)
Rapid methods in clinical microbiology. Rapid methods. Overview and prospects for the future. (1985) (0)
The Use of Cephalothin in the Treatment of Serious Infections. (1965) (0)
Characterization of an unusual microaerophilic organism closely related to Bacteroides gracilis. (1993) (0)
Effect of Bile and Desoxycholate on Gram-Negative Anaerobic Bacteria (1970) (0)
induced diarrhea and colitis13 (1980) (0)
Biochemical and genetic characterization of a Pre vote / / a intermediahigrescens-I i ke organ ism (2008) (0)
Clinical features and diagnosis of anaerobic pleuropulmonary infections. (1970) (0)
Clostridium difficile: its role in intestinal disease continued. (1988) (0)
Bronchopulmonary Geotrichosis in the Compromised Host. (1972) (0)
Effect ofBileandDesoxycholate on Gram-Negative (1970) (0)
Letter: Faecal cholesterol conversion and polyp status. (1976) (0)
Anaerobic infections. (1980) (0)
Anaerobic susceptibility testing using a Bioscreen C analyzer (1997) (0)
Editorial Note: Modifications to Reviews of Infectious Diseases (1990) (0)
Antibacterial Sensitivity ofBfiJdobacterium (Lactobacillus bifidus) (1967) (0)
993 C. DIFFICILE RELATED COLITIS IN CHILDREN FOLLOWING ANTIMICROBIAL THERAPY (1981) (0)
Current status of anaerobic bacteriology and anaerobic infections. (1975) (0)
TODAY'S PRACTICE OF CARDIOPULMONARY MEDICINE Bacterial infoctions of the Lung* (2017) (0)
Selective medium for Bacteroides gracilis (Reply) (1991) (0)
Clinical Features of Legionnaires’ Disease (2018) (0)
In Vitro Susceptibilities of the Bacteroides fragilis Group Species: Change in Isolation Rates Significantly Affects Overall Susceptibility Data (2002) (0)
DUPLICATE SUBMISSION AND PUBLICATION OF CORRESPONDENCE. EDITOR'S REPLY (1993) (0)
Hospital-Acquired Gram Negative Bacillary Infections. (1964) (0)
Susceptibility of anaerobic bacteria to thiamphenicol. (1984) (0)
InVitro Activities ofTwoNewGlycylcyclines, N,N-Dimethylglycylamido Derivatives ofMinocycline and6-Demethyl-6-Deoxytetracycline, against 339Strains ofAnaerobic Bacteria (1994) (0)
Enumeration and differential plate counting of microbial colonies by a stereoscopic microscope pattern cover method (1968) (0)
SELECTIVE MEDIUM FOR BACTEROIDES GRACILIS. AUTHOR'S REPLY (1991) (0)
100 Anaerobic Infections ± A Clinical Overview (0)
Back to basics. (1983) (0)
Dr. Finegold Replies. (1976) (0)
Drugs of choice for specific bacteria. (1969) (0)
Selective MediumforIsolation ofBacteroides gracilis (1990) (0)
Introduction to the Society for Intestinal Microbial Ecology and Disease (1984) (0)

This paper list is powered by the following services:

Other Resources About Sydney M. Finegold

en.wikipedia.org

What Schools Are Affiliated With Sydney M. Finegold?

Sydney M. Finegold is affiliated with the following schools: